ISO 25539-1 PDF

Give feedback ISO specifies requirements for the evaluation of endovascular systems prostheses and delivery systems and requirements with respect to nomenclature, design attributes and information supplied by the manufacturer based upon current medical knowledge. Guidance for the development of in vitro test methods is included in an informative annex to this document. This document can be considered as a supplement to ISO , which specifies general requirements for the performance of non-active surgical implants. ISO is applicable to endovascular systems used to treat aneurysms, stenoses or other vascular anomalies or pathologies e. Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses. Although uses of endovascular systems other than treatment of arterial aneurysms or stenoses e.

Author:Gardakus Keramar
Country:Mali
Language:English (Spanish)
Genre:Health and Food
Published (Last):8 January 2015
Pages:358
PDF File Size:20.52 Mb
ePub File Size:14.50 Mb
ISBN:937-7-22104-503-2
Downloads:56343
Price:Free* [*Free Regsitration Required]
Uploader:Kajikree



Full Description BS EN ISO specifies requirements for the evaluation of endovascular systems prostheses and delivery systems and requirements with respect to nomenclature, design attributes and information supplied by the manufacturer based upon current medical knowledge.

Guidance for the development of in vitro test methods is included in an informative annex to this document. This document can be considered as a supplement to ISO , which specifies general requirements for the performance of non-active surgical implants. This document is applicable to endovascular systems used to treat aneurysms, stenoses or other vascular anomalies or pathologies e. Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses.

Although uses of endovascular systems other than treatment of arterial aneurysms or stenoses e. Similarly, specific prosthesis configurations e. This document is not applicable to vascular occluders, with the exception of contra-lateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis.

Although contralateral iliac artery occluders when used as an integral part of aorto-uni-iliac endovascular prosthesis are within the scope of this document, specific requirements and testing are not described for these devices.

Balloons used to achieve adequate apposition of the prosthesis with the vessel wall or overlapping components are within the scope of this document, even if they are not integral to the endovascular system. This document provides requirements beyond the requirements of ISO , specific to the use of balloons with endovascular prostheses.

This document is not applicable to procedures and devices used prior to the introduction of the endovascular system, such as balloon angioplasty devices. The valve component of valved conduits constructed with an endovascular prosthesis component and the combination of the valved component and the endovascular prosthesis component are excluded from the scope of this document.

This document can be helpful in identifying the appropriate evaluation of the endovascular prosthesis component of a valved conduit, but specific requirements and testing are not described for these devices.

Pharmacological aspects of drug eluting or drug coated endovascular prostheses are not addressed in this document. This document does not address the requirements for, and the evaluation of, viable tissues and nonviable biologic materials used in the construction of endovascular prostheses. Cross References:.

HERB DEWEY PSYCHOBABBLE PDF

ISO 25539-1

Full Description BS EN ISO specifies requirements for the evaluation of endovascular systems prostheses and delivery systems and requirements with respect to nomenclature, design attributes and information supplied by the manufacturer based upon current medical knowledge. Guidance for the development of in vitro test methods is included in an informative annex to this document. This document can be considered as a supplement to ISO , which specifies general requirements for the performance of non-active surgical implants. This document is applicable to endovascular systems used to treat aneurysms, stenoses or other vascular anomalies or pathologies e. Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses.

EPOX 8KA PDF

CSN EN ISO 25539-1

Guidance for the development of in vitro test methods is included in an informative annex to this document. This document can be considered as a supplement to ISO , which specifies general requirements for the performance of non-active surgical implants. ISO is applicable to endovascular systems used to treat aneurysms, stenoses or other vascular anomalies or pathologies e. Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses. Although uses of endovascular systems other than treatment of arterial aneurysms or stenoses e. Similarly, specific prosthesis configurations e.

TERAPIA GERSONA PDF

EVS-EN ISO 25539-1:2009/AC:2011

Document Center Inc. The following bibliographic material is provided to assist you with your purchasing decision: ISO specifies requirements for the evaluation of endovascular systems prostheses and delivery systems and requirements with respect to nomenclature, design attributes and information supplied by the manufacturer based upon current medical knowledge. Guidance for the development of in vitro test methods is included in an informative annex to this document. This document can be considered as a supplement to ISO , which specifies general requirements for the performance of non-active surgical implants. ISO is applicable to endovascular systems used to treat aneurysms, stenoses or other vascular anomalies or pathologies e. Some of the requirements are specific to endovascular treatment of arterial aneurysms or stenoses.

Related Articles